Practice parameters for the medical therapy of obstructive sleep apnea: Standards of Practice Committee of the American Academy of Sleep Medicine

Sleep

Volumn 29, Issue 8, 2006, Pages 1031-1035

  Morgenthaler, Timothy I ^a   Kapen, Sheldon ^b   Lee Chiong, Teofilo ^c   Alessi, Cathy ^d   Boehlecke, Brian ^e   Brown, Terry ^f   Coleman, Jack ^g   Friedman, Leah ^h   Kapur, Vishesh ⁱ   Owens, Judith ^j   Pancer, Jeffrey ^g   Swick, Todd ^k  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f St Joseph Memorial Hospital   (United States)

^g Stanford University ^*

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j RHODE ISLAND HOSPITAL   (United States)

^k The Houston Sleep Center   (United States)

more..

Author keywords

Bariatric surgery; Medical therapy; Obstructive sleep apnea; Positional therapy; Selective serotonergic uptake inhibitors; Supplementary oxygen; Weight reduction

Indexed keywords

CORTICOSTEROID; DECONGESTIVE AGENT; ESTROGEN; METHYLXANTHINE; MIRTAZAPINE; MODAFINIL; PROTRIPTYLINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

AIRWAY PRESSURE; BARIATRIC SURGERY; BODY POSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH HAZARD; HUMAN; MEDICAL PRACTICE; MORBID OBESITY; OBESITY; OXYGEN THERAPY; PATIENT POSITIONING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SLEEP APNEA SYNDROME; WEIGHT REDUCTION;

EID: 33747462560     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/29.8.1031     Document Type: Review

References (65)

1. Marin J, Carrizo S, Vicente E, et al. Long-term cardiovascular out-comes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365:1046-1053
2. Dhillon S, Chung S, Fargher T, et al. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens 2005; 18:594-600
3. Naughton M. The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment. Curr Cardiol Rep 2005; 7:211-215
4. Jung H, Han H, Lee J. Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients. Am J Kidney Dis 2005; 45:875-882
5. Amin R, Kimball T, Kalra M, et al. Left ventricular function in chil-dren with sleep-disordered breathing. Am J Cardiol 2005; 95:801-804
6. Haas D, Foster G, Nieto F, et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005; 111:614-621
7. Shahar E, Whitney C, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163:19-25
8. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice Parameters for the Use of Continuous and Bilevel Positive Airway Pressure Devices to Treat Adult Patients with Sleep-Related Breathing Disorders. Sleep 2006; 29:375-380
9. Kushida CA, Morgenthaler TI, Littner MR, et al. Practice Parameters for the Treatment of Snoring and Obstructive Sleep Apnea with Oral Appliances: An Update for 2005. Sleep 2006: 29:240-243
10. Zozula R, Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001; 7:391-398
11. Thorpy M, Chesson A, Derderian S, et al. Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical modifications of the upper airway. Report of the American Sleep Disorders Association. Sleep 1996; 19:152-155
12. Veasey S, Strohl K. Medical Therapy for Obstructive Sleep Apnea. Sleep 2006 (submitted)
13. Sackett D. Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol 1993; 9:487-489
14. Eddy D, ed. A manual for assessing health practices and designing practice policies: the explicit approach. Philadelphia, PA: American College of Physicians, 1992
15. Rauscher H, Formanek D, Popp W, et al. Nasal CPAP and weight loss in hypertensive patients with obstructive sleep apnoea. Thorax 1993; 48:529-533
16. Schwartz AR, Gold AR, Schubert N, et al. Effect of Weight Loss on Upper Airway Collapsibility in Obstructive Sleep Apnea. Am Rev Resp Dis 1991; 144:494-498
17. Smith P, AR Gold DM, EF Haponik, ER Bleecker. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103:850-855
18. Kajaste S, Brander PE, Telakivi T, et al. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004; 5:125-131
19. Guardiano SA, Scott JA, Ware JC, et al. The Long-Term Results of Gastric Bypass on Indexes of Sleep Apnea. Chest 2003; 124:1615-1619
20. Scheuller M, Weider D. Bariatric surgery for treatment of sleep apnea syndrome in 15 morbidly obese patients: Long-term results: Otolaryngol Head Neck Surg 2001; 125:299-302
21. Valencia-Flores M, Orea A, Herrera M, et al. Effect of Bariatric Surgery on Obstructive Sleep Apnea and Hypopnea Syndrome, Electrocardiogram, and Pulmonary Arterial Pressure. Obes Surg 2004; 14:755-762
22. Buchwald H, Avidor Y, Braundwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292:1724-1737
23. Pillar G, Peled R, Lavie P. Recurrence of Sleep Apnea Without Concomitant Weight Increase 7.5 Years After Weight Reduction Surgery. Chest 1994; 106:1702-1704
24. Sampol G, Munoz X, Sagales MT, et al. Long-term efficacy of dietary weight loss in sleep apnoea/hypopnea syndrome. Eur Respir J. 1998; 12:1156-1159
25. Livingston E. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surgery 2004; 188:105-110
26. Hanzel DA, Proia NG, Hudgel DW. Response of Obstructive Sleep Apnea to Fluoxetine and Protriptyline. Chest 1991; 100:416-421
27. Berry R, Yamaura E, Gill K, et al. Acute Effects of Paroxetine on Genioglossus Activity in Obstructive Sleep Apnea. Sleep 1999; 22:1087-1092
28. Kraiczi H, Hedner J, Ejnell H, et al. Effect of Serotonin Uptake Inhibition on Breathing during Sleep and Daytime Symptoms in Obstructive Sleep Apnea. Sleep 1999; 22:61-67
29. Brownell L, West P, Sweatman P, et al. Protriptylline in obstructive sleep apnea: a double-blind trial. N Engl J Med 1982; 307:1037-1042
30. Stepanski E, Conway W, Young D, et al. A double-blind trial of protriptyline in the treatment of sleep apnea syndrome. Henry Ford Hosp Med J 1988; 36:5-8
31. Whyte K, Gould G, Airlie M, et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome. Sleep 1988; 11:463-472
32. Smith PL, Haponik EF, Allen RP, et al. The effects of protriptyline in sleep-disordered breathing. Am Rev Respir Dis 1983; 127:8-13
33. Espinoza H, Antic R, Thornton A, et al. The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis. 1987; 136:80-84
34. Saletu B, Oberndorfer S, Anderer P, et al. Efficiency of continuous positive airway pressure versus theophylline therapy in sleep apnea: comparative sleep laboratory studies on objective and subjective sleep and awakening quality. Neuropsychobiology 1999; 39:151-159
35. Hein H, Behnke G, Jorres RA, et al. The therapeutic effect of theophylline in mild obstructive sleep Apnea/Hypopnea syndrome: results of repeated measurements with portable recording devices at home. Eur J Med Res 2000; 5:391-399
36. Pickett C, Regensteiner J, Woodard W, et al. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J Appl Physiol 1989; 66:1656-1661
37. Keefe D, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause 1999; 6:196-200
38. Manber R, Kuo T, Cataldo N, et al. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep 2003; 26:163-168
39. Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003; 12:239-254
40. Block AJ, Wynne JW, Boysen PG, et al. Menopause, medroxyprogesterone and breathing during sleep. Am J Med 1981; 70:506-510
41. Cistulli P, Barnes D, Grunstein R, et al. Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 1994; 49:699-702
42. Polo-Kantola P, Rauhala E, Helenius H, et al. Breathing during sleep in menopause: a randomized, controlled, crossover trial with estrogen therapy. ACOG Educ Bull 2003; 102:68-75
43. Hannhart B, Pickett C, Moore L. Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia. J Appl Physiol 1990; 68:1909-1916
44. Manson JE, Martin KA. Postmenopausal Hormone-Replacement Therapy. N Engl J Med 2001; 345:34-40
45. Arnulf I, Homeyer P, Garma L, et al. Modafinil in obstructive sleep apnea syndrome: a pilot study in 6 patients. Respiration 1997; 64:159-161
46. Kingshott RN, Venelle M, Coleman EL, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163:918-923
47. Pack A, Black J, Schwartz J, et al. Modafinil as an adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001:1675-1681
48. Black J, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea-hypopnea syndrome. Sleep 2005; 28:464-471
49. Schwartz J, Hirshkowitz M, Erman MK, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: A 12 week open-label study. Chest 2003; 124:2192-2199
50. Heitmann J, Cassel W, Grote L, et al. Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? Clin Pharmacol Therapy 1999; 65:328-335
51. Chauncey J, Aldrich M. Preliminary findings in the treatment of obstructive sleep apnea with transtracheal oxygen. Sleep 1990; 13:167-174
52. Farney RJ, Walker JM, Cloward TV, et al. Sleep-Disordered Breathing Associated with Long-tern Opioid Therapy. Chest 2003; 123:632-639
53. Landsberg R, Friedman M, Ascher-Landsberg J. Treatment of hypoxemia in obstructive sleep apnea. Am J Rhinol 2001; 15:311-313
54. Phillips BA, Schmitt FA, Berry DT, et al. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest 1990; 98:325-330
55. Braver HM, Block AJ. Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep 1994; 17:516-521
56. Graf P. Rhinitis medicamentosa: a review of causes and treatment. 21-29.
57. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 2004; 59:50-55
58. Joe S, Benson A. Nonallergic rhinitis. In: Cummings CW, ed. Otolaryngology: Head Neck Surg Philadelphia: Mosby, Inc., 2005; 996-999
59. Jokic R, Klimaszewski A, Crossley M, et al. Positional Treatment vs Continuous Positive Airway Pressure in Patients With Positional Obstructive Sleep Apnea Syndrome. Chest 1999; 115:771-781
60. Skinner M, Kingshott R, Jones D, et al. Elevated posture for the management of obstructive sleep apnea. Sleep Breath 2004; 8:193-200
61. Cartwright R, Ristanovic R, Diaz F, Caldarelli D, Alder G. A Comparative Study of Treatments for Positional Sleep Apnea. Sleep 1991; 14:546-552
62. Kushida CA, Littner MR, Morgenthaler T, et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005; 28:499-521.
63. Chesson AL, Jr., Berry RB, Pack A. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 2003; 26:907-913.
64. Kushida CA, Rao S, Guilleminault C. Cervical positional effects on snoring and apneas. Sleep Res Online 1999; 2:7-10
65. Zuberi N, Rekab K, Nguyen H. Sleep apnea avoidance pillow effects on obstructive sleep apnea syndrome and snoring. Sleep Breath 2004; 8:201-207